Nantahala Capital Management »

Vistagen Therapeutics Ord shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.3M 1.8M 5.14

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Nantahala Capital Management
Commodore Capital
Citadel Advisors
Sphera Funds Management
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
William Blair $ Company
Gts Securities
Citigroup

View all funds holding Vistagen Therapeutics Ord